In this study, we investigated the changes of physiological indexes, serum metabolites and gut microbiome of T2DM paitents treated with metformin or empagliflozin among 4 monthes.
The dataset used in the paper is a collection of patient data for type 2 diabetes mellitus (T2DM) prediction. The dataset includes 4,597 patients with various characteristics such as age, sex, height,
Type 2 Diabetes Mellitus (T2DM) is a chronic and sometimes debilitating disease that affects millions of adults in the USA. Metformin is commonly prescribed for T2DM; yet some T2DM patients do not tol
In this study, we investigated the changes of physiological indexes, serum metabolites and gut microbiome of T2DM paitents treated with metformin or empagliflozin among 4 monthes.
